US Oncology, Inc. - Strategy and SWOT Report
Datamonitor, June 2011, Pages: 34
The US Oncology, Inc.’s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Scope:
- Provides detailed information on US Oncology, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting US Oncology, Inc. in the form of a SWOT analysis
- Offers an in-depth view of the business model of US Oncology, Inc. including a breakdown and examination of key business segments
- Provides intelligence on US Oncology, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- Captures the latest news about US Oncology, Inc., such as business expansion, restructuring, and contract wins
- Includes large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
This report includes US Oncology, Inc.'s business description, segment overview, company history, products and services, SWOT analysis, management statement, key executives and biographies, key competitors, locations and subsidiaries, contact information, latest news, and corporate activity including M&A, private equity, venture financing, public offerings, private placements and partnerships, and a list of legal and financial advisors.
Reasons to Purchase:
- Gain understanding of the company and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess prospective partners, vendors and suppliers
- Support sales activities by understanding your customers' businesses better
- Stay up to date on your competitors' business structure, strategy and prospects
Company Snapshot US Oncology, Inc.: Key Employees US Oncology, Inc.: Major Products and Services US Oncology, Inc.: Company History US Oncology, Inc.: Management Statement US Oncology, Inc.: Locations and Subsidiaries US Oncology, Inc.: Key Competitors US Oncology, Inc.: Company Analysis US Oncology, Inc.: Business Description US Oncology, Inc.: SWOT Analysis US Oncology, Inc.: SWOT Overview US Oncology, Inc.: Strengths US Oncology, Inc.: Weaknesses US Oncology, Inc.: Opportunities US Oncology, Inc.: Threats US Oncology, Inc.: Corporate Financial Deals Activity US Oncology, Inc.: Financial Deals Overview US Oncology, Inc.: Targets and Partners US Oncology, Inc.: Top Deals 2007 -YTD-2011 US Oncology, Inc.: Advisors US Oncology, Inc.: Top Legal Advisors US Oncology, Inc.: Top Financial Advisors US Oncology, Inc.: Mergers and Acquisitions US Oncology, Inc.: Capital Raising US Oncology, Inc.: Partnership US Oncology, Inc.: Private Equity and Ownership US Oncology, Inc.: Recent Developments US Oncology, Inc.: News and Events Summary US Oncology, Inc.: Corporate Governance US Oncology, Inc.: Financial Deals US Oncology, Inc.: IT Spending Announcements Appendix Contact Us Methodology Definitions About Datamonitor List of Tables Table 1: US Oncology, Inc.: Key Facts Table 2: US Oncology, Inc.: Key Employees Table 4: US Oncology, Inc.: Key Competitors Table 5: US Oncology, Inc.: Deal Activity by Deal Type - Volume (TTM) Table 6: US Oncology, Inc.: Deal Activity by Deal Type - Volume (2007 - YTD-2011) Table 7: US Oncology, Inc.: Targets and Partners Table 8: US Oncology, Inc.: Top Deals 2007 -YTD-2011 Table 9: US Oncology, Inc.: Legal Advisor Ranking by Value (US$m) Table 10: US Oncology, Inc.: Financial Advisor Ranking by Value (US$m) Table 11: US Oncology, Inc.: M&A Volume and Value Trend (2007 - YTD-2011) Table 12: US Oncology, Inc.: M&A Activity by Geography (2007 - YTD-2011) Table 13: US Oncology, Inc.: Capital Raising Volume and Value Trend (2007 - YTD-2011) Table 14: US Oncology, Inc.: Capital Raising by Deal Type (2007 - YTD-2011) Table 15: US Oncology, Inc.: Partnership Volume and Value Trend (2007 - YTD-2011) Table 16: US Oncology, Inc.: Partnership Trend by Deal Type (2007 - YTD-2011) Table 17: US Oncology, Inc.: Private Equity and Ownership Volume and Value Trend (2007 - YTD-2011) Table 18: US Oncology, Inc.: Private Equity and Ownership Volume by Deal Type (2007 - YTD-2011) Table 19: US Oncology, Inc.: News and Events Summary Table 20: US Oncology, Inc.: Corporate Governance Table 21: US Oncology, Inc.: Financial Deals Table 22: US Oncology, Inc.: IT Spending Announcements List of Figures Figure 1: US Oncology, Inc.: Deal Activity by Deal Type - Volume (TTM) Figure 2: US Oncology, Inc.: Deal Activity by Deal Type - Volume (2007 - YTD-2011) Figure 3: US Oncology, Inc.: M&A Volume and Value Trend (2007 - YTD-2011) Figure 4: US Oncology, Inc.: M&A Activity by Geography (2007 - YTD-2011) Figure 5: US Oncology, Inc.: Capital Raising Volume and Value Trend (2007 - YTD-2011) Figure 6: US Oncology, Inc.: Capital Raising by Deal Type (2007 - YTD-2011) Figure 7: US Oncology, Inc.: Partnership Volume and Value Trend (2007 - YTD-2011) Figure 8: US Oncology, Inc.: Partnership Trend by Deal Type (2007 - YTD-2011) Figure 9: US Oncology, Inc.: Private Equity and Ownership Volume and Value Trend (2007 - YTD-2011) Figure 10: US Oncology, Inc.: Private Equity and Ownership Volume by Deal Type (2007 - YTD-2011)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
